The following information is current as of 10:00pm on tuesday the 19th of May - It is part of my own due diligence and any inquiries please forward to [email protected] thankyou.
Technical Chart: This is the current HCT chart showing a base forming with all moving averages lined up and back in an upwards trend - previous high of 34 to be tested soon.
HolistaCollTech Ltd, The scope for growth is in this company is simply incredible – they have multiple revenue streams across several different sectors with all of them being in the commercialization/sales phase of the project after many years of research and development.
HolistaColltech Ltd is a research-driven biotech company and is the result of the merger of Holista Biotech SdnBhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients. Holista, listed on the Australian Stock Exchange (ASX:HCT), researches, develops, manufactures and markets health-style products to address the unmet and growing needs of natural medicine.
1 Year share performance from low (.004) to high (.024) = 500%
Cash on hand at end of year : $101k – This is extremely rare for a company to have such a low cash balance, but given that a HUGE portion of the top 20 is held By directors – it shows how important it is to minimize dilution for them and fellow shareholders – less free float means less liquidity when the stock does start To run, And huge gains can be easily made once the sell side dries up.
Cash now : Circa $4.3million – hard to calculate as they have multiple sales avenues and revenue incoming at increasing frequencies (see pic for cash raise/CPA)
Announcements: Holista has been extremely busy this year and are very proactive with there plans to bring their product onto the global scene With huge demand, and with the formation of several recent distribution partnerships I imagine this trend will continue at an accelerating rate. Rather thanPut it into my own words I will insert their latest announcements in chronological order to allow you to see how quickly they are growing, and it shows they have a clearly defined path to success.
Firstly, this Ann from last year announcing they have filed a patent for their CBD absorption technology
The following was the initial Ann which spiked my interest in HCT
Shortly after they announced they were developing a nasal balm using their patented path-way solution
Next, they announced they were entering into a collaboration agreement to develop the nasal balm as well as extending distribution rights for path-away
Followed by Dr Martin – the creator of path away joining Holista’s advisory board
3rd of March – Letter signed by Global Infections Control Consultants LLC (the developer of pathaway and natshield) and Holista – giving Holista GLOBAL distribution rights.
MAIDEN SALES OF $1.4M FOR 80LESS™ SUGAR FORMULATION
COMMENCEMENT OF TESTS IN U.K. LAB OF PATHAWAY®‘S EFFICACY AGAINST COVID-19 ANDOTHER CORONAVIRUSES: -
HOLISTA APPOINTS EXCLUSIVE U.S. DISTRIBUTOR FOR NATSHIELD ™ SANITISER WITH CONFIRMED SALES ORDER OF A$3.0 MILLION IN FIRST YEAR – 19th March
Skin Elements Enters Binding Agreement with HolistaColltech To Launch All-Natural Skin Friendly Sanitiser within Australia
HOLISTA’S U.S. DISTRIBUTOR INCREASES ORDERS OF NATSHIELD™ AMOUNTING TO A$3.8M – 9th April, just 3 weeks after signing a $3m a year distribution agreement That total value of orders necessary for the contract has been eclipsed in just three weeks.…. HUGE.
CONVERSION OF PERFORMANCE RIGHTS
HOLISTA ANNOUNCES SUCCESSFUL U.K. LAB TESTS SHOWING NATSHIELD’S ACTIVE INGREDIENT EFFICACY AGAINST THE SURROGATE OF COVID-19
Clarification of previous announcement-Acceleration of NatshieldGlobal Roll-out After Raising $2.2M - CPA now terminated after raising $6.5M since February 2020
NATSHIELDTO BE TRIALED BY THE INTELLIGENT STERILIZATION ROBOTS IN ASIAN INTERNATIONAL AIRPORT
HOLISTA FILES GLOBAL PATENT FOR NATSHIELD NASAL SANITIZING BALM
APPOINTMENT OF U.K. DISTRIBUTOR FOR NATSHIELD™ SANITISER
Now that we have covered all the recent announcements, Lets have a quick look at their Natshield product range so far.
And now let’s look at HolistaColltechs own line of products currently available for purchase
Now to finish let’s look at the top 20 and management
TOP 20:
Note: Will analyse at a later date but important thing to note here is the huge amount held by management - This is so massively important in small cap stocks – skin in the game, interests aligned. NB: Dr. Rajen Manicka recently received 8m well earned performance shares after the date of this list. - This list is outdated (from their annual report), from what i have heard Acuity is gone and there is 3 new holders on the list with none of the rest decreasing their holdings.
“The mission of HolistaCollTech Ltd is to provide society with all natural health-style products through innovations that advances the eminence of life and meeting customer needs, providing employees with momentous work environment and advancement opportunities, enhancing partner′s business and investors with a greater rate of return.”
HCT Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
(20min delay)